{Reference Type}: Journal Article
{Title}: The Structure-Antiproliferative Activity Relationship of Pyridine Derivatives.
{Author}: Villa-Reyna AL;Perez-Velazquez M;González-Félix ML;Gálvez-Ruiz JC;Gonzalez-Mosquera DM;Valencia D;Ballesteros-Monreal MG;Aguilar-Martínez M;Leyva-Peralta MA;
{Journal}: Int J Mol Sci
{Volume}: 25
{Issue}: 14
{Year}: 2024 Jul 11
{Factor}: 6.208
{DOI}: 10.3390/ijms25147640
{Abstract}: Pyridine, a compound with a heterocyclic structure, is a key player in medicinal chemistry and drug design. It is widely used as a framework for the design of biologically active molecules and is the second most common heterocycle in FDA-approved drugs. Pyridine is known for its diverse biological activity, including antituberculosis, antitumor, anticoagulant, antiviral, antimalarial, antileishmania, anti-inflammatory, anti-Alzheimer's, antitrypanosomal, antimalarial, vasodilatory, antioxidant, antimicrobial, and antiproliferative effects. This review, spanning from 2022 to 2012, involved the meticulous identification of pyridine derivatives with antiproliferative activity, as indicated by their minimum inhibitory concentration values (IC50) against various cancerous cell lines. The aim was to determine the most favorable structural characteristics for their antiproliferative activity. Using computer programs, we constructed and calculated the molecular descriptors and analyzed the electrostatic potential maps of the selected pyridine derivatives. The study found that the presence and positions of the -OMe, -OH, -C=O, and NH2 groups in the pyridine derivatives enhanced their antiproliferative activity over the cancerous cellular lines studied. Conversely, pyridine derivatives with halogen atoms or bulky groups in their structures exhibited lower antiproliferative activity.